Bioprocess Research and Training Academy Guangzhou (BRTAG) , China
Launched in 2020, BRTAG is a Chinese Government funded GMP bioprocessing facility equipped with cutting edge single use technology from Cytiva. BRTAG joined NIBRT’s global partnership programme to deliver localized NIBRT training courses in the Guangdong-Hong Kong Macao Greater Bay Area, an active economic area in southern China attracting millions of high-tech talents as well as 10,000+ thriving biological companies.
BRTAG provides both theoretical and practical biomanufacturing training based on the NIBRT curriculum, devoted to workforce development for China’s biopharma industry and global pharma.
BRTAG is located in the International Bio Island and operated by a subsidiary of Guangzhou Hi-tech Investment Group, under the administration of Guangzhou Development District.
The NIBRT Global Partner Programme supports an international alliance of leading training and education organisations to help address the global shortage of a skilled biopharma workforce.
In September 2020, the Bioprocess Research and Training Academy Guangzhou (BRTAG) joined the Global Partners Programme. BRTAG is the first NIBRT partner in the Greater China area and provides a bioprocess training facility with a full range of single-use upstream and downstream equipment, offering trainees hands-on practical opportunities ranging from fundamental aseptic skills to complex biomanufacturing and bioprocessing procedures in a GMP environment.
